TLDR: Barclays strategic investment in Ubyx aims to build interoperability infrastructure for digital money Ubyx develops clearing systems for tokenised depositsTLDR: Barclays strategic investment in Ubyx aims to build interoperability infrastructure for digital money Ubyx develops clearing systems for tokenised deposits

Barclays Invests in Ubyx to Build Digital Money Infrastructure for Tokenised Deposits and Stablecoins

2026/01/08 05:10
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR:

  • Barclays strategic investment in Ubyx aims to build interoperability infrastructure for digital money
  • Ubyx develops clearing systems for tokenised deposits and regulated stablecoins across blockchains
  • Bank participation enables par value redemption through regulated channels for digital wallets
  • Partnership reflects growing regulatory clarity and adoption beyond cryptocurrency use-cases globally

Barclays has announced a strategic investment in Ubyx Inc., a United States-based clearing system for digital money. 

The investment focuses on tokenised deposits and regulated stablecoins infrastructure. This move marks another step in traditional banking’s embrace of blockchain-based financial technology. 

The partnership aims to improve interoperability across digital asset platforms and networks.

Strategic Partnership Addresses Industry Infrastructure Gaps

Barclays’ investment in Ubyx addresses a critical need in the evolving digital asset ecosystem. The partnership reflects growing recognition that connectivity infrastructure remains essential for mainstream adoption.

As tokens, blockchains, and wallets proliferate, financial institutions need robust systems for integration.

Ryan Hayward, Head of Digital Assets and Strategic Investments at Barclays, commented on the investment’s strategic rationale. “Interoperability is essential to unlock the full potential of digital assets,” Hayward stated. 

He added that specialist technology will play a pivotal role in delivering connectivity and infrastructure. “We are pleased to be joining Ubyx on their journey as we drive forward our shared ambition,” he noted.

Barclays’ involvement brings traditional banking expertise to the digital money infrastructure layer. The bank’s participation provides legitimacy and resources to accelerate development. 

This collaboration demonstrates how established financial institutions are actively shaping the future of digital assets.

Building Global Acceptance Network for Regulated Digital Money

Tony McLaughlin, CEO of Ubyx, outlined the company’s vision for transforming digital money infrastructure. “Our mission is to build a common globalised acceptance network for regulated digital money,” McLaughlin explained. 

He emphasized that bank participation is vital to provide par value redemption through regulated channels. McLaughlin also highlighted the industry transformation, stating that regulated firms will offer digital wallets alongside traditional accounts.

The Ubyx platform seeks to establish standardized pathways for tokenised deposits and regulated stablecoins. This network operates within compliance frameworks while enabling broader financial innovation. 

The company’s approach prioritizes regulatory adherence while building next-generation payment infrastructure.

The investment timing aligns with favorable market conditions for digital money innovation. Regulatory clarity has advanced across multiple jurisdictions in recent months. 

Evidence shows adoption expanding beyond cryptocurrency use-cases into mainstream financial applications. Both Barclays and Ubyx have committed to responsible development within regulatory boundaries. 

The partnership positions both organizations to capitalize on emerging opportunities in tokenised money markets. Their joint efforts focus on building infrastructure that meets both innovation goals and compliance requirements.

The post Barclays Invests in Ubyx to Build Digital Money Infrastructure for Tokenised Deposits and Stablecoins appeared first on Blockonomi.

Market Opportunity
Lorenzo Protocol Logo
Lorenzo Protocol Price(BANK)
$0.03952
$0.03952$0.03952
-3.96%
USD
Lorenzo Protocol (BANK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09